Evidence map›Paper›PMID 41117854›Full record

ArticleCellular and molecular neurobiology2025

Microglia-Derived Extracellular Vesicles Enhance Oligodendrocyte Maturation by Transcriptionally Regulating Mitochondrial Molecular Pathways.

Stefano Raffaele, Marta Lombardi, Davide Marangon, Maria P Abbracchio, Davide Lecca, Claudia Verderio, Marta Fumagalli

Abstract read
In one paragraph

Article in Cellular and molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Stefano RaffaeleDepartment of Pharmaceutical Sciences, Università Degli Studi Di Milano, Via Balzaretti 9, 20133, Milan, Italy.ORCID http://orcid.org/0000-0002-2734-5418
Marta LombardiNational Research Council of Italy, Institute of Neuroscience (IN-CNR), Via Follereau 3, 20854, Vedano Al Lambro, MB, Italy.ORCID http://orcid.org/0000-0001-6703-7121
Davide MarangonDepartment of Pharmaceutical Sciences, Università Degli Studi Di Milano, Via Balzaretti 9, 20133, Milan, Italy.ORCID http://orcid.org/0000-0003-2606-8110
Maria P AbbracchioDepartment of Pharmaceutical Sciences, Università Degli Studi Di Milano, Via Balzaretti 9, 20133, Milan, Italy.ORCID http://orcid.org/0000-0002-7833-3388
Davide LeccaDepartment of Pharmaceutical Sciences, Università Degli Studi Di Milano, Via Balzaretti 9, 20133, Milan, Italy.ORCID http://orcid.org/0000-0002-3258-363X
Claudia VerderioNational Research Council of Italy, Institute of Neuroscience (IN-CNR), Via Follereau 3, 20854, Vedano Al Lambro, MB, Italy.ORCID http://orcid.org/0000-0001-7216-5873
Marta FumagalliDepartment of Pharmaceutical Sciences, Università Degli Studi Di Milano, Via Balzaretti 9, 20133, Milan, Italy. marta.fumagalli@unimi.it.ORCID http://orcid.org/0000-0002-0158-842X

Funding

Fondazione Cariplo 2015-0910NextGenerationEU G53D23004440006
6 · The paper itself

Abstract

Degeneration of myelinating oligodendrocytes and the resulting breakdown of the myelin sheath are key drivers of neurodegeneration and disability across numerous central nervous system pathologies. Thus, a compelling strategy to preserve neuronal function is to promote endogenous myelin repair by oligodendrocyte precursor cells (OPCs). Extracellular vesicles (EVs) secreted by pro-regenerative microglia have been shown to enhance OPC maturation and remyelination across different experimental models. Yet, the mechanisms by which microglia-derived EVs exert their beneficial effects on OPCs are not fully understood. In this study, we performed transcriptomic profiling of primary murine OPCs treated during differentiation with EVs obtained from donor microglia following stimulation with pro-inflammatory cytokines (i-EVs), interleukin-4 (IL4-EVs), or mesenchymal stem cells in the presence of the inflammatory cocktail (MSC-EVs; GEO accession number: GSE304130). Compared to controls, IL4-EVs and MSC-EVs induced robust changes in gene expression, whereas i-EVs elicited far fewer alterations. Using bioinformatic analyses, we identified the molecular pathways significantly modulated by microglial EVs, revealing a large overlap between IL4-EV and MSC-EV targets. Notably, many of these shared pathways centered on mitochondrial function and bioenergetic metabolism. Upstream regulatory network inference further pinpointed candidate transcription factors and kinases that may drive EV-induced transcriptional reprogramming in OPCs. Hence, our findings indicate that rewiring mitochondria-associated pathways is a core mechanism underlying the pro-differentiation effects of microglial EVs on OPCs. Elucidating these intracellular circuits will open new avenues for developing EV-based or mitochondria-targeted remyelinating therapies.

Indexed as

Cell DifferentiationExtracellular VesiclesMicrogliaMitochondriaOligodendrogliaTranscription, GeneticAnimalsMiceMice, Inbred C57BLSignal TransductionExtracellular vesiclesMicrogliaMitochondriaNeuroinflammationOligodendrocytesOPCsRemyelination

Identifiers

PMID41117854
PMCPMC12540241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.